Search

Your search keyword '"Celli, Bartolome R."' showing total 166 results

Search Constraints

Start Over You searched for: Author "Celli, Bartolome R." Remove constraint Author: "Celli, Bartolome R." Publisher american thoracic society Remove constraint Publisher: american thoracic society
166 results on '"Celli, Bartolome R."'

Search Results

1. Genetically Predicted Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease.

2. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

3. Differential Diagnosis of Suspected COPD Exacerbations in the Acute Care Setting: Best Practice

4. To Our Knowledge, You Are Not the First...

6. Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook.

8. Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice.

9. Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward

10. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal

11. Reply to Thomson, to Neder et al., and to Wouters

12. Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review

13. From GOLD 0 to Pre-COPD

14. Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-Blind Clinical Trial

15. β-blocker therapy and clinical outcomes in patients with moderate chronic obstructive pulmonary disease and heightened cardiovascular risk. an observational substudy of SUMMIT

20. Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee

22. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial

23. At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease

24. β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT

27. Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction

28. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

29. Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease

30. Exome Sequencing Analysis in Severe, Early-Onset Chronic Obstructive Pulmonary Disease

31. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events: A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.

32. Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk.

33. B Cell–Activating Factor. An Orchestrator of Lymphoid Follicles in Severe Chronic Obstructive Pulmonary Disease

34. An Official American Thoracic Society/European Respiratory Society Statement: Research Questions in Chronic Obstructive Pulmonary Disease

35. Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease. Development and Validation of the COPD Lung Cancer Screening Score

36. Quantitative Computed Tomography Measures of Pectoralis Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease. A Cross-Sectional Study

39. Testing Reported Genetic Determinants Of Lung Function From Large Population-Based Studies: Association With COPD And EQTL Analysis

40. Interstitial Lung Abnormalities And Reduced Exercise Capacity

41. Soluble Receptor For Advanced Glycation Endproducts (sRAGE) Is A Biomarker Of Emphysema In The ECLIPSE Cohort

42. Common Genetic Risk Variants Correlate With Hypoxemia Within COPD Cases In A Genome-Wide Association Study

44. Comorbidities, Gender And Mortality Differences In Patients With COPD

46. Serum Biomarkers In COPD Survivors And Controls. Longitudinal Analysis

49. A Genome-Wide Association Study Of Bronchodilator Responsiveness In Four Cohorts With COPD

Catalog

Books, media, physical & digital resources